P3862A prospective global registry on oral antithrombotic treatment in patients with atrial fibrillation: GLORIA-AF Phase III baseline characteristics

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal 2018-08, Vol.39 (suppl_1)
Hauptverfasser: Huisman, M V, Diener, H.-C, Dubner, S J, Halperin, J L, Rothman, K J, Ma, C.-S, Lu, S, Paquette, M, Teutsch, C, Franca, L R, Zint, K, Lip, G Y H
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue suppl_1
container_start_page
container_title European heart journal
container_volume 39
creator Huisman, M V
Diener, H.-C
Dubner, S J
Halperin, J L
Rothman, K J
Ma, C.-S
Lu, S
Paquette, M
Teutsch, C
Franca, L R
Zint, K
Lip, G Y H
description
doi_str_mv 10.1093/eurheartj/ehy563.P3862
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_eurheartj_ehy563_P3862</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_eurheartj_ehy563_P3862</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_1093_eurheartj_ehy563_P38623</originalsourceid><addsrcrecordid>eNqdkN1KxDAQhYMoWH9eQeYFupu2NrTeFXG1ILiIF96FtEy3WdKkTKLSF_F5jav4AF7NYeYcZuZj7Crjq4zXxRrfaERFYb_GcSlFsdoWlciPWJKVeZ7W4ro8ZgnP6jIVono9ZWfe7znnlchEwj4P5gZmcn7GPuh3hJ1xnTJAuNM-0ALOgqPYUDboMJKbOhd0D4FQhQltAG1hVkFH6eEjWkAF0jEw6I60MXHk7A3cPz49t03abGA7Ko_Qti10URhtEfpRkeoDUlype3_BTgZlPF7-1nMmNncvtw9pH-_0hIOcSU-KFplx-U1B_lGQPxTk4bHi38EveYxwig</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>P3862A prospective global registry on oral antithrombotic treatment in patients with atrial fibrillation: GLORIA-AF Phase III baseline characteristics</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Huisman, M V ; Diener, H.-C ; Dubner, S J ; Halperin, J L ; Rothman, K J ; Ma, C.-S ; Lu, S ; Paquette, M ; Teutsch, C ; Franca, L R ; Zint, K ; Lip, G Y H</creator><creatorcontrib>Huisman, M V ; Diener, H.-C ; Dubner, S J ; Halperin, J L ; Rothman, K J ; Ma, C.-S ; Lu, S ; Paquette, M ; Teutsch, C ; Franca, L R ; Zint, K ; Lip, G Y H ; GLORIA-AF Investigators</creatorcontrib><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1093/eurheartj/ehy563.P3862</identifier><language>eng</language><ispartof>European heart journal, 2018-08, Vol.39 (suppl_1)</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Huisman, M V</creatorcontrib><creatorcontrib>Diener, H.-C</creatorcontrib><creatorcontrib>Dubner, S J</creatorcontrib><creatorcontrib>Halperin, J L</creatorcontrib><creatorcontrib>Rothman, K J</creatorcontrib><creatorcontrib>Ma, C.-S</creatorcontrib><creatorcontrib>Lu, S</creatorcontrib><creatorcontrib>Paquette, M</creatorcontrib><creatorcontrib>Teutsch, C</creatorcontrib><creatorcontrib>Franca, L R</creatorcontrib><creatorcontrib>Zint, K</creatorcontrib><creatorcontrib>Lip, G Y H</creatorcontrib><creatorcontrib>GLORIA-AF Investigators</creatorcontrib><title>P3862A prospective global registry on oral antithrombotic treatment in patients with atrial fibrillation: GLORIA-AF Phase III baseline characteristics</title><title>European heart journal</title><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqdkN1KxDAQhYMoWH9eQeYFupu2NrTeFXG1ILiIF96FtEy3WdKkTKLSF_F5jav4AF7NYeYcZuZj7Crjq4zXxRrfaERFYb_GcSlFsdoWlciPWJKVeZ7W4ro8ZgnP6jIVono9ZWfe7znnlchEwj4P5gZmcn7GPuh3hJ1xnTJAuNM-0ALOgqPYUDboMJKbOhd0D4FQhQltAG1hVkFH6eEjWkAF0jEw6I60MXHk7A3cPz49t03abGA7Ko_Qti10URhtEfpRkeoDUlype3_BTgZlPF7-1nMmNncvtw9pH-_0hIOcSU-KFplx-U1B_lGQPxTk4bHi38EveYxwig</recordid><startdate>20180801</startdate><enddate>20180801</enddate><creator>Huisman, M V</creator><creator>Diener, H.-C</creator><creator>Dubner, S J</creator><creator>Halperin, J L</creator><creator>Rothman, K J</creator><creator>Ma, C.-S</creator><creator>Lu, S</creator><creator>Paquette, M</creator><creator>Teutsch, C</creator><creator>Franca, L R</creator><creator>Zint, K</creator><creator>Lip, G Y H</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20180801</creationdate><title>P3862A prospective global registry on oral antithrombotic treatment in patients with atrial fibrillation: GLORIA-AF Phase III baseline characteristics</title><author>Huisman, M V ; Diener, H.-C ; Dubner, S J ; Halperin, J L ; Rothman, K J ; Ma, C.-S ; Lu, S ; Paquette, M ; Teutsch, C ; Franca, L R ; Zint, K ; Lip, G Y H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_1093_eurheartj_ehy563_P38623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huisman, M V</creatorcontrib><creatorcontrib>Diener, H.-C</creatorcontrib><creatorcontrib>Dubner, S J</creatorcontrib><creatorcontrib>Halperin, J L</creatorcontrib><creatorcontrib>Rothman, K J</creatorcontrib><creatorcontrib>Ma, C.-S</creatorcontrib><creatorcontrib>Lu, S</creatorcontrib><creatorcontrib>Paquette, M</creatorcontrib><creatorcontrib>Teutsch, C</creatorcontrib><creatorcontrib>Franca, L R</creatorcontrib><creatorcontrib>Zint, K</creatorcontrib><creatorcontrib>Lip, G Y H</creatorcontrib><creatorcontrib>GLORIA-AF Investigators</creatorcontrib><collection>CrossRef</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huisman, M V</au><au>Diener, H.-C</au><au>Dubner, S J</au><au>Halperin, J L</au><au>Rothman, K J</au><au>Ma, C.-S</au><au>Lu, S</au><au>Paquette, M</au><au>Teutsch, C</au><au>Franca, L R</au><au>Zint, K</au><au>Lip, G Y H</au><aucorp>GLORIA-AF Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P3862A prospective global registry on oral antithrombotic treatment in patients with atrial fibrillation: GLORIA-AF Phase III baseline characteristics</atitle><jtitle>European heart journal</jtitle><date>2018-08-01</date><risdate>2018</risdate><volume>39</volume><issue>suppl_1</issue><issn>0195-668X</issn><eissn>1522-9645</eissn><doi>10.1093/eurheartj/ehy563.P3862</doi></addata></record>
fulltext fulltext
identifier ISSN: 0195-668X
ispartof European heart journal, 2018-08, Vol.39 (suppl_1)
issn 0195-668X
1522-9645
language eng
recordid cdi_crossref_primary_10_1093_eurheartj_ehy563_P3862
source Oxford University Press Journals All Titles (1996-Current); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title P3862A prospective global registry on oral antithrombotic treatment in patients with atrial fibrillation: GLORIA-AF Phase III baseline characteristics
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T19%3A01%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P3862A%20prospective%20global%20registry%20on%20oral%20antithrombotic%20treatment%20in%20patients%20with%20atrial%20fibrillation:%20GLORIA-AF%20Phase%20III%20baseline%20characteristics&rft.jtitle=European%20heart%20journal&rft.au=Huisman,%20M%20V&rft.aucorp=GLORIA-AF%20Investigators&rft.date=2018-08-01&rft.volume=39&rft.issue=suppl_1&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1093/eurheartj/ehy563.P3862&rft_dat=%3Ccrossref%3E10_1093_eurheartj_ehy563_P3862%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true